Registration was successful!
Please follow the link from the email sent to

Patient With Drug Resistant Tuberculosis Isolated at US Heath Facility

© Photo : nih.govMark O. Hatfield Clinical Research Center on the National Institutes of Health, Bethesda, Maryland
Mark O. Hatfield Clinical Research Center on the National Institutes of Health, Bethesda, Maryland - Sputnik International
Subscribe
A patient with a rare type of drug resistant Tuberculosis is isolated at the US National Institutes of Health (NIH) in Bethesda, Maryland.

A Kansas man experienced organ failure and died after being bitten by a tick. - Sputnik International
US Health Officials Discover New Deadly Tick Virus
WASHINGTON (Sputnik) A patient with a rare type of drug resistant Tuberculosis (TB) is in isolated treatment at the US National Institutes of Health (NIH) in Bethesda, Maryland, NIH said in a statement made to Sputnik on Tuesday.

“On Friday, June 5, NIH admitted a patient with extensively drug-resistant tuberculosis (XDR-TB), a relatively rare type of TB that is resistant to many medications typically used to treat TB,” NIH said.

The patient was transferred to the Bethesda, Maryland health facility via special air and ground ambulances, NIH said.

NIH said that the patient is currently being treated in an isolation room at the NIH Clinical Center, which is designed to treat people with respiratory infections. In the past, the NIH Clinical Center was also used to treat patients who suffered from the deadly Ebola virus.

“NIH is taking every precaution to ensure the safety of all concerned, and the situation is of minimal risk to other Clinical Center patients, NIH staff, and the public,” the medical research center said.

The NIH declined to tell Sputnik the gender of the patient, but US media reported that the patient is a woman who may have been exposed to the virus while traveling from India via Chicago O’Hare International Airport.

Extensively Drug-resistant TB is resistant to the strongest drugs used to fight TB, leaving patients with few effective treatment options, according to the US Centers for Disease Control.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала